US Pharmacopeia develops and improves its class approach for ensuring quality biopharmaceuticals.
Tina S. Morris, PhD
Advertisement
Tina S. Morris, PhD, is vice president of Biologics & Biotechnology at United States Pharmacopeia (USP)
Articles by Tina S. Morris, PhD
USP is advancing efforts to develop a guidance for evaluating bioassays.
Modern bioassays enable more accurate potency testing.
Advertisement
Latest Updated Articles
USP Product-Class Standards for BiologicsMarch 1st 2011
Industry Input Needed on Bioassay StandardsJuly 1st 2010
Advertisement
Advertisement
Trending on BioPharm International
1
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
2
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
3
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
4
The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
5